Moderate- and high-intensity training can upregulate the expression of the muscle synthetic factors IGF-1 and irisin, promoting muscle hypertrophy and ameliorating skeletal muscle atrophy in COPD patients. The gene discussed is FNDC5; the disease is chronic obstructive pulmonary disease.